PRiME 7th Annual Symposium: A Global Community Accelerating Innovation

On February 20, 2026, PRiME welcomed nearly 200 trainees, faculty, industry experts, and researchers from across the globe to the PRiME 7th Annual Symposium, which took place at the Leslie Dan Faculty of Pharmacy, University of Toronto. This year’s theme highlighted transformative technologies reshaping drug screening, diagnostics, and therapeutic development.

Lisa Dolovich, Professor and Dean, Leslie Dan Faculty of Pharmacy, University of Toronto, gave opening remarks along with PRiME leadership Molly Shoichet and Akshita Vincent, highlighting PRiME's vision of connecting global hubs and scientists to deliver precision medicine and building a platform for innovation and entrepreneurship.

**Lisa Dolovich**, University of Toronto

Left to right: **Lisa Dolovich**, University of Toronto; **Molly Shoichet**, University of Toronto; **Akshita Vincen**t, University of Toronto; **Micheline Piquette-Miller**, University of Toronto;.

Thank you to our Keynote Speakers: Berend Snijder, Shana Kelley, and Alberto Nobili for their invigorating and insightful talks!

Left to right: **Berend Snijder**, Botnar Institute of Immune Engineering and ETH Zürich; **Shana Kelley**, Biohub & Northwestern University; **Alberto Nobili**, Bayer Co.Lab.

In partnership with The Hospital for Sick Children (HSC) and University Health Network (UHN), we were pleased to announce the 2026 PRiME UHN Fellows and the 2026 HSC Fellows:

Left to right: **Carolyn Cummins**, University of Toronto; **Molly Shoichet**, University of Toronto; **Jingan Chen**, University of Toronto; **Anthony Altieri**, University of Toronto; **Zhengchao Dou**, University of Toronto; **Sarvatit Patel**, University of Toronto; **Akshita Vincent**, University of Toronto.

The program continued with our electrifying Industry Panel: Spotlight on innovation: Steering next-generation platforms from concept to clinic, featuring panelists Philip Kim, Jennifer Moody, Julie Audet, Matteo Aldeghi, and Chadwick King, and moderated by Leah Cowen, Vice-President, Research and Innovation, and Strategic Initiatives, University of Toronto.

Left to right: **Philip Kim**, Fable Therapeutics; **Chadwick King**, Amgen; **Jennifer Moody**, Danaher.

Following the industry panel, Leah Cowen concluded the PRiME 7th Annual Symposium with closing remarks, celebrating the global community of innovators PRiME has brought together, underscoring the critical importance of collaboration across academia, industry, health systems, and government to address complex health challenges

We wish to extend our gratitude to our sponsors, Frontier: A Versant Discovery Engine, Bayer, Amgen, Genome Canada, Toronto Innovation Acceleration Partners, and Ontario Bioscience Innovation Organization, for their support of this event. Your support was integral to the success of the PRiME 7^th Annual Symposium, and to our growing community of researchers, clinician scientists, industry pioneers, investors, and policymakers.

Left to right: **Alberto Nobili**, Bayer Co.Lab; **Molly Shoichet**, University of Toronto; **Akshita Vincent**, University of Toronto; **Matteo Aldeghi**, Bayer.

Left to right: **Rene Hubert**, Amgen; **Molly Shoichet**, University of Toronto; **Shana Kelley**, Biohub; **Akshita Vincent**, University of Toronto.

We are deeply grateful to all our speakers, panelists, and industry presenters for sharing their expertise; and to all the attendees for the meaningful dialogue that will shape PRiME’s ongoing efforts to build an innovative and connected scientific community.

Thank you to our organizing committee, each of whom contributed to making the PRiME 7th Annual Symposium a success.